| Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer (NCT00104767) | Jonsson Comprehensive Cancer Center | 2009-01-01 |
| Evaluation Of The Efficacy Of The Combination Of Axitinib With Pemetrexed And Cisplatin In The Treatment Of Non-Squamous Non-Small Cell Lung Cancer (NCT00768755) | Pfizer | 2009-01-01 |
| Stem Cell Therapy to Improve the Muscle Function of Patients With Partly Denervated Muscles of the Arm (NCT00755586) | Leiden University Medical Center | 2009-01-01 |
| Treatment of Recurrent Primary or Secondary Central Nervous System (CNS) Lymphoma With ALIMTA (Pemetrexed) (NCT00916630) | Massachusetts General Hospital | 2009-01-01 |
| Transvaginal NOTES Cholecystectomy: Phase I/II Mexico Clinical Trial (NCT00710502) | Universidad Juárez del Estado de Durango | 2009-01-01 |
| Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy (NCT01083368) | Case Comprehensive Cancer Center | 2009-01-01 |
| The Effect of Amiloride and Spironolactone in Healthy Persons (NCT00857909) | Regional Hospital Holstebro | 2009-01-01 |
| Pertussis Vaccine in Healthy Pregnant Women (NCT00707148) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Phase 1 Study for Safety of ACHN-490 (NCT00822978) | Achaogen, Inc. | 2009-01-01 |
| Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI) (NCT00829985) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| To Evaluate 24-hr Glucose After OD vs BD AZD1656 (NCT00819884) | AstraZeneca | 2009-01-01 |
| Photobiomodulation to Alter Cerebral Blood Flow and to Affect the Emotional Status of Patients With Major Depression (NCT00961454) | Massachusetts General Hospital | 2009-01-01 |
| Simvatstatin Used to Treat Pulmonary Hypertension (NCT00538044) | Capital Medical University | 2009-01-01 |
| Relative Bioavailability of Dextromethorphan Syrup in Comparison to Dextromethorphan Soft Pastilles in Healthy Male and Female Subjects (NCT02191709) | Boehringer Ingelheim | 2009-01-01 |
| Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer (NCT00943956) | Institut du Cancer de Montpellier - Val d'Aurelle | 2009-01-01 |
| A Safety Study of ARRY-300 in Healthy Subjects (NCT00828165) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2009-01-01 |
| Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Study of KW-2449 in Acute Myelogenous Leukemia (AML) (Protocol Number: 2449-US-002) (NCT00779480) | Kyowa Kirin Co., Ltd. | 2009-01-01 |
| Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome (NCT00829439) | Boston Children's Hospital | 2009-01-01 |
| Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3) (NCT00599755) | Merck Sharp & Dohme LLC | 2009-01-01 |
| Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer (NCT00719199) | EMD Serono | 2009-01-01 |
| Study Evaluating TwoTablet Formulations of Neratinib (HKI-272) (NCT00814060) | Puma Biotechnology, Inc. | 2009-01-01 |
| Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules (NCT00821444) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-01-01 |
| Intraperitoneal Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Cancer of the Peritoneal Cavity (NCT00825201) | City of Hope Medical Center | 2009-01-01 |
| Evaluation of Cissus Verticillata L. Infusion in Controlling Type 2 Diabetes (NCT01145534) | Federal University of Paraíba | 2009-01-01 |
| Trial on Postoperative Outcomes According to the Number of Trocar During Laparoscopic Appendectomy (NCT00816933) | The Catholic University of Korea | 2009-01-01 |
| Radiolabel ADME (Absorption, Distribution, Metabolism, and Excretion) Study Of [14C] PF-00868554 In Healthy Adult Male Subjects (NCT00823745) | Pfizer | 2009-01-01 |
| BIBW 2992 Administered as Tablet (Final Formulation) Compared to BIBW 2992 Drinking Solution and BIBW 2992 Tablet (Trial Formulation II) in Healthy Male Volunteers (NCT02171715) | Boehringer Ingelheim | 2009-01-01 |
| Extracorporeal Shockwave Therapy for the Treatment of Advanced Angina Pectoris (NCT01219218) | Medispec | 2009-01-01 |
| Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes (NCT00863954) | pico-tesla Magnetic Therapies, LLC | 2009-01-01 |
| Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of Furosemide (NCT00909519) | NicOx | 2009-01-01 |
| The Effects of Hyperbaric Oxygen Therapy (HBOT) on Acute Thermal Burns (NCT00824551) | Singapore General Hospital | 2009-01-01 |
| Effects of Using Betahistine to Treat Adults With Attention Deficit Hyperactivity Disorder (NCT00829881) | P2D, Inc. | 2009-01-01 |
| An Open-Label Study of QD Oral Administration of Tivozanib (AV-951) in Subjects With Non-Small Cell Lung Cancer (NSCLC) (NCT00826878) | AVEO Pharmaceuticals, Inc. | 2009-01-01 |
| Sorafenib and LBH589 in Hepatocellular Carcinoma (HCC) (NCT00823290) | University of Erlangen-Nürnberg Medical School | 2009-01-01 |
| Lenalidomide In Patients With Acute Myeloid Leukemia (NCT00839059) | University of Ulm | 2009-01-01 |
| Efficacy, Tolerability and Safety of RKI983 (0.05% & 0.10%) vs Xalatan in Patients With POAG or Ocular Hypertension (NCT00846989) | Novartis Pharmaceuticals | 2009-01-01 |
| TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation (NCT00812292) | Tibotec Pharmaceuticals, Ireland | 2009-01-01 |
| Safety and Immune Response to Two Doses of rDEN2/4delta30 Dengue Vaccine (NCT00920517) | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-01-01 |
| Two Anesthetic Techniques in Magnetic Resonance Imaging (MRI) (NCT00894751) | Children's Hospital Medical Center, Cincinnati | 2009-01-01 |
| High Dose Inhaled Mannitol Study (NCT01076491) | Syntara | 2009-01-01 |
| A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma (NCT00821249) | Pfizer | 2009-01-01 |
| Activity Study of Sunitinib In Metastatic Pretreated Urothelial Cancer (NCT00818350) | Campania Younger Oncologists Association | 2009-01-01 |
| Dasatinib In Combination With Weekly Paclitaxel For Patients With Metastatic Breast Carcinoma CA 180 194 (NCT00820170) | Memorial Sloan Kettering Cancer Center | 2009-01-01 |
| Safety Evaluation of ExAblate MRgFUS for Prostate Cancer (NCT00811265) | InSightec | 2009-01-01 |
| Hematopoietic Stem Cell Support Versus Insulin in T1D (NCT01285934) | Northwestern University | 2009-01-01 |
| Study Evaluating Single Doses of BLI-489 in Healthy Subjects (NCT00820404) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-01-01 |
| Safety, Tolerability and Pharmacokinetics of NN1731 in Healthy Volunteers (NCT00822185) | Novo Nordisk A/S | 2009-01-01 |
| Eniluracil Hand Foot Syndrome (NCT00827580) | West Virginia University | 2009-01-01 |
| Phase1, Single Dose, Crossover Study to Determine Bioequivalence (NCT00786240) | Pfizer | 2009-01-01 |
| ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan (NCT00836888) | Ono Pharmaceutical Co., Ltd. | 2009-01-01 |
| A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients (NCT00741377) | Novartis Pharmaceuticals | 2009-01-01 |
| Phase I/II Study of Escalating Doses of Idarubicin Orally Given With Oral Cyclophosphamide, Etoposide, Prednisolone and Intravenous Rituximab in Elderly Patient With Disseminated High Grade Non Hodgkin Lymphoma (NCT01958996) | Poitiers University Hospital | 2009-01-01 |
| Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract (NCT00927329) | University of North Carolina, Chapel Hill | 2009-01-01 |
| Study Evaluating Single Doses of ILV-095 in Healthy Subjects (NCT00822835) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-01-01 |
| Reduction of Bacteria in MRSA Positive Ulcers (NCT00771368) | Nitric BioTherapeutics, Inc | 2009-01-01 |
| Acupuncture for Back and Neck Pain in an Emergency Room Setting (NCT00859365) | Assaf-Harofeh Medical Center | 2009-01-01 |
| Addition of Modulators of Homocysteine to Adalimumab Therapy in the Treatment of Moderate to Severe Plaque Psoriasis (NCT01704599) | Wayne State University | 2009-01-01 |
| Safety Study of ARQ 197 in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) (NCT00802555) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2009-01-01 |
| CpG 7909/Montanide ISA 720 With or Without Cyclophosphamide in Combination Either With NY-ESO-1-derived Peptides or the NY-ESO-1 Protein for NY-ESO-1-expressing Tumors (NCT00819806) | Hassane M. Zarour, MD | 2009-01-01 |
| Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment (NCT00829205) | Cancer Research UK | 2009-01-01 |
| Sorafenib-RT in Treating Hepatocellular Carcinoma (SHEP) (NCT00892658) | University Health Network, Toronto | 2009-01-01 |
| Hepatic Impairment Study (NCT00829231) | Bayer | 2009-01-01 |
| Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes (NCT00949091) | Takeda | 2009-01-01 |
| EFFECTS OF RejuvaMatrix ™ ON TELOMERES (NCT04048044) | Holos Institutes of Health, Inc | 2009-01-01 |
| Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients (NCT00844597) | Sarepta Therapeutics, Inc. | 2009-01-01 |
| Safety Study for NST-001 and the Neuroject Injection Set to Treat Tinnitus (NCT00957788) | NeuroSystec Corporation | 2009-01-01 |
| A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers (NCT00813241) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2009-01-01 |
| Pharmacokinetic/Pharmacodynamic Study of Ilaprazole to Evaluate the Effect of CYP Genetic Polymorphism (NCT01688544) | Inje University | 2009-01-01 |
| Safety and Efficacy Trial of a RNActive®-Derived Prostate Cancer Vaccine in Hormone Refractory Disease (NCT00831467) | CureVac | 2009-01-01 |
| A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027) (NCT00836498) | Merck Sharp & Dohme LLC | 2009-01-01 |
| Stereotactic Body Radiation Therapy (SBRT) as a Boost After Definitive Concurrent Chemoradiation (ChemoRT) for Non-Small Cell Lung Cancer (NSCLC) GCC 0516 (NCT00818714) | University of Maryland, Baltimore | 2009-01-01 |
| Thorough Corrected QT Interval (QTc) Study To Evaluate Possible Effects of Prucalopride on ECG Parameters (NCT00903747) | Movetis | 2009-01-01 |
| Study Evaluating the Safety, Tolerability and Pharmacokinetics of Desvenlafaxine Succinate SR in Healthy Chinese Male and Females (NCT00818155) | Wyeth is now a wholly owned subsidiary of Pfizer | 2009-01-01 |
| A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF (NCT00765050) | PETHEMA Foundation | 2009-01-01 |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin (NCT00822770) | M.D. Anderson Cancer Center | 2009-01-01 |
| Pain Catastrophizing as a Cause for Systemic Inflammation (NCT00823147) | Beth Darnall, PhD | 2009-01-01 |
| Dose-Finding Pilot Study of ACTH in Patients With Idiopathic Membranous Nephropathy (NCT00805753) | Mayo Clinic | 2009-01-01 |
| A PET Study With ORM-12741 (NCT00829907) | Orion Corporation, Orion Pharma | 2009-01-01 |
| Vorinostat in Combination With Vinorelbine in Patients With Advanced Cancer (NCT00801151) | Institut Claudius Regaud | 2009-01-01 |
| Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis (NCT01348451) | Neuralstem Inc. | 2009-01-01 |
| Heterosubtypic Immune Responses to Influenza in Older People (NCT00798343) | University Hospitals, Leicester | 2009-01-01 |
| Ocular Biodistribution Study for Topically Applied ESBA105 (NCT00820014) | ESBATech AG | 2009-01-01 |
| Influence of a Prematuration Culture With a Phosphodiesterase-3 Inhibitor (PDE3-I) on Embryonic Aneuploidy Rate and Developmental Potential (NCT00822874) | Universitair Ziekenhuis Brussel | 2009-01-01 |
| Identifying Therapeutic Factors in an 8-Week (30 Hour) Mindfulness-Based Stress Reduction (MBSR) Program (NCT01599143) | North York General Hospital | 2009-01-01 |
| Stem Cell Therapy in Duchenne Muscular Dystrophy (NCT02241434) | Neurogen Brain and Spine Institute | 2009-01-01 |
| Ascending Multiple-Dose Study of BMS-817378 in Subjects With Advanced Cancers (NCT00792558) | Bristol-Myers Squibb | 2009-01-01 |
| Oral Forodesine Hydrochloride (BCX-1777) in Patients With Recurrent or Refractory T/NK-cell Malignancies (NCT00823355) | Mundipharma K.K. | 2009-01-01 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39393406 in Healthy Participants (NCT02023255) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2009-01-01 |
| Pharmacodynamic/Pharmacokinetic Study of AQW051 in Schizophrenia (NCT00825539) | Novartis Pharmaceuticals | 2009-01-01 |
| RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS (NCT00819546) | Richard Stone, MD | 2009-01-01 |
| Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741 (NCT00817544) | Orion Corporation, Orion Pharma | 2009-01-01 |
| Azathioprine & Allopurinol in Inflammatory Bowel Disease Patients (NCT00849368) | University of Zurich | 2009-01-01 |
| Dose Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma (NCT00734188) | Pain Therapeutics | 2009-01-01 |
| Use of Botulinum Toxin to Treat Psoriasis (NCT00816517) | University of Minnesota | 2009-01-01 |
| Cycling Exercise With Functional Electrical Stimulation Improves Postural Control in Stroke Patients (NCT01099878) | Chung Shan Medical University | 2009-01-01 |
| Extended Study of Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer (NCT01414296) | Progenics Pharmaceuticals, Inc. | 2009-01-01 |
| Brain Imaging Study in Subjects With Alzheimer Disease in Comparison to Healthy Subjects (NCT00870519) | Institute for Neurodegenerative Disorders | 2009-01-01 |
| A Study to Evaluate Safety, Tolerability, Plasma Drug Levels, and Cognitive Response Following Multiple Doses of a Drug in Healthy Elderly Participants. (NCT00832052) | Pfizer | 2009-01-01 |
| Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer (NCT00783172) | Milton S. Hershey Medical Center | 2009-01-01 |
| Profermin® in Active Ulcerative Colitis (NCT01245465) | Nordisk Rebalance A/S | 2009-01-01 |